EULAR 2018
Read the full Report (pdf)
European League Against Rheumatism 13-16 June 2018 Amsterdam, the Netherlands
Featured articles
CONTENTS
Online First
Rheumatoid Arthritis
Early, intensive rheumatoid arthritis treatment seems to normalise mortality rates
Switching to biosimilar bDMARDs is safe and efficacious
No significant differences when tapering TNF blockers versus csDMARDs
Biologic drug levels and infection risk, and clinical effectiveness of sarilumab
Confirmation of long-term safety profile adalimumab across indications
Ankylosing Spondylitis
Clinical effect of vedolizumab on articular manifestations spondyloarthritis associated with IBD
Synergistic effect NSAIDs plus TNFi in slowing radiographic progression in ankylosing spondylitis patients
Low bone mineral density is common in axial spondyloarthritis; more awareness required
Osteoporosis and Osteoarthritis
